死亡竞争风险对4期CKD肾衰竭风险估计的影响
基于加拿大阿尔伯塔省2002-2014年成人4期CKD人群数据,比较删失死亡法与竞争风险法估计肾衰竭风险。30,801名参与者中18%发生肾衰竭、53%死亡;删失法随时间高估肾衰竭风险,5年高估7%、10年高估19%,死亡高风险者高估更明显。肾衰竭风险计算器应纳入死亡作为竞争风险。
要点
- 4期CKD患者死亡风险远高于肾衰竭,删失死亡会高估肾衰竭风险。
- 删失法5年高估肾衰竭风险7%、10年高估19%,死亡高风险者更明显。
- 肾衰竭风险计算器应纳入死亡作为竞争风险以提高准确性。
核心结论
- 肾衰竭风险计算器应纳入死亡作为竞争风险,以提高对患者和提供者的准确性和实用性。
研究设计与样本
- 基于加拿大阿尔伯塔省2002-2014年成人4期CKD(持续eGFR 15-30 ml/min per 1.73 m2)的 population-based 实验室与行政数据。
- 共纳入30,801名参与者,106,447患者年风险,平均年龄77岁。
- 分析至肾衰竭、死亡或删失的最早时间,比较删失死亡法与将死亡视为竞争事件的方法,校正年龄、性别、糖尿病、心血管疾病、eGFR和白蛋白尿。
主要发现
- 18%发生肾衰竭,53%死亡。
- 死亡或肾衰竭联合终点5年观察风险64%、10年87%。
- 标准删失死亡法估计联合终点风险5年76%、7.5年>100%。
- 删失死亡法对肾衰竭风险的高估随时间增加,5年高估7%、10年高估19%,死亡高风险者更明显。
- 5年绝对风险高估范围从1%(无糖尿病、心血管疾病、白蛋白尿且eGFR 25 ml/min per 1.73 m2的女性,9% vs 8%)到27%(有糖尿病、心血管疾病、白蛋白尿>300 mg/d且eGFR 20 ml/min per 1.73 m2的男性,78% vs 51%)。
关键数值与推荐
- 4期CKD定义为持续eGFR 15-30 ml/min per 1.73 m2。
- 删失死亡法5年高估肾衰竭风险7%、10年高估19%。
- 5年绝对风险高估从1%(低死亡风险女性)到27%(高死亡风险男性)。
临床怎么用
- 评估4期CKD患者肾衰竭风险时应使用竞争风险方法,避免删失死亡法高估风险。
- 对死亡高风险患者(如合并糖尿病、心血管疾病、白蛋白尿)更需注意竞争风险校正。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most kidney failure risk calculators are based on methods that censor for death. Because mortality is high in people with severe, nondialysis-dependent CKD, censoring for death may overestimate their risk of kidney failure. METHODS: Using 2002-2014 population-based laboratory and administrative data for adults with stage 4 CKD in Alberta, Canada, we analyzed the time to the earliest of kidney failure, death, or censoring, using methods that censor for death and methods that treat death as a competing event factoring in age, sex, diabetes, cardiovascular disease, eGFR, and albuminuria. Stage 4 CKD was defined as a sustained eGFR of 15-30 ml/min per 1.73 m2. RESULTS: Of the 30,801 participants (106,447 patient-years at risk; mean age 77 years), 18% developed kidney failure and 53% died. The observed risk of the combined end point of death or kidney failure was 64% at 5 years and 87% at 10 years. By comparison, standard risk calculators that censored for death estimated these risks to be 76% at 5 years and >100% at 7.5 years. Censoring for death increasingly overestimated the risk of kidney failure over time from 7% at 5 years to 19% at 10 years, especially in people at higher risk of death. For example, the overestimation of 5-year absolute risk ranged from 1% in a woman without diabetes, cardiovascular disease, or albuminuria and with an eGFR of 25 ml/min per 1.73 m2 (9% versus 8%), to 27% in a man with diabetes, cardiovascular disease, albuminuria >300 mg/d, and an eGFR of 20 ml/min per 1.73 m2 (78% versus 51%). CONCLUSIONS: Kidney failure risk calculators should account for death as a competing risk to increase their accuracy and utility for patients and providers.
引用
- Ravani P, Fiocco M, Liu P, et al. Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 CKD. J Am Soc Nephrol. 2019. PMID: 31540963. doi:10.1681/ASN.2019060640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。